Health in El Salvador 1,364 indicators covering health for El Salvador. IndicatorLatest Year10-yr change Rank 2.2.1 Prevalence of stunting among children under 5 10 2022 down 35.5% 94th Incidence of malaria 0 per 1,000 population at risk 2024 — 79th Reported number of children receiving antiretroviral therapy 62 2025 down 77.3% 83rd Concentrations of fine particulate matter 25.75 2023 down 14.2% 60th Death rate due to road traffic injuries 20.9 per 100,000 population 2019 down 6.3% 65th New or unknown treatment history cases: Pulmonary, bacteriologically 2,815 2023 up 97.7% 77th Medical doctors not further defined 10,194 2023 down 11.7% 56th Constant stillbirth rate 8.13 2030 unchanged 101st ENAP target met stillbirth rate 6.19 2030 down 20.8% 112th Stillbirth rate high-income country 2.8 2030 down 59.9% 1st Stillbirths remain constant projection 765 2030 down 5.6% 105th Stillbirth maintained projection 581 2030 down 25.4% 106th Stillbirth ENAP 2030 target met projection 581 2030 down 25.4% 105th Stillbirth high-income country average rate matched projection 262 2030 down 62.3% 106th Stillbirth rate current trends 6.19 2030 down 20.8% 112th Life satisfaction vs. life expectancy 72.1 years 2023 up 1.2% 151st Estimate of current cigarette smoking prevalence 5.8% 2030 down 21.6% 132nd Estimate of current cigarette smoking prevalence (%) 6.1% 2030 down 22.8% 128th Tuberculosis patients who tested positive for HIV 126 patients 2021 down 35.1% 79th Number of children aged 6-59 months with anaemia 142.16 2019 down 6.0% 101st Prevalence of anaemia in children aged 6-59 months 24.6% 2019 down 0.4% 107th Mean hemoglobin level of children aged 6-59 months 118 2019 unchanged 74th Estimated number of MDR/RR-TB incident cases 140 2024 up 159.3% 86th Neonatal mortality rate - Remains constant 4.34 2030 unchanged 139th Neonatal mortality rate - Current trends maintained 3.34 2030 down 19.5% 144th Neonatal mortality rate - High-income country average rate matched 2.8 2030 down 30.5% 1st Neonatal mortality rate - SDG target met 3.34 2030 down 19.5% 144th Under 5 mortality rate - Remains constant 10.05 2030 unchanged 122nd Under 5 mortality rate - Current trends maintained 7.85 2030 down 18.5% 133rd Under 5 mortality rate - High-income country average rate matched 5.06 2030 down 43.0% 124th Under 5 mortality rate - SDG target met 7.85 2030 down 18.5% 133rd Mortality rate age 10-19 - Remains constant 5.33 2030 down 18.0% 94th Mortality rate age 10-19 - Current trends maintained 5.33 2030 down 18.0% 84th Mortality rate age 10-19 - High-income country average rate matched 2.13 2030 down 61.4% 147th Neonatal deaths - Remains constant 405 2030 down 4.5% 115th Neonatal deaths - Current trends maintained 312 2030 down 23.2% 119th Neonatal deaths - SDG target met 312 2030 down 23.2% 117th Under-five deaths - Remains constant 944 2030 down 4.6% 113th Under-five deaths - Current trends maintained 738 2030 down 22.2% 115th Under-five deaths - SDG target met 738 2030 down 22.2% 112th Deaths age 10 to 19 - Remains constant 716 2030 down 5.7% 93rd Deaths age 10 to 19 - Current trends maintained 554 2030 down 23.7% 100th Number of deaths attributed to non-communicable diseases, by type of 4,452 2019 up 5.2% 123rd Hepatitis B surface antigen (HBsAg) prevalence 0.0% 2024 — 132nd Mortality caused by road traffic injury 20.9 per 100,000 population 2019 down 15.0% 65th Mortality caused by road traffic injury, female 9.1 per 100,000 female population 2019 up 3.4% 74th Mortality caused by road traffic injury, male 34.2 per 100,000 male population 2019 down 19.0% 56th Countries with birth registration data that are at least 90 percent 1 2024 unchanged 2nd Share of one-year-olds who received the inactivated polio vaccine 98.0% 2024 down 1.0% 33rd Deaths in armed conflicts by country, annual growth rate -100 % change on previous year 2023 unchanged 33rd Deaths in armed conflicts by region, annual growth rate -100 % change on previous year 2023 unchanged 33rd Proportion of health care facilities with limited water services 32 2015 unchanged 16th Tuberculosis patients living with HIV receiving antiretroviral therapy 126 patients 2021 down 15.4% 74th HIV-positive TB patients on ART (antiretroviral therapy) 94.0% 2024 up 11.9% 80th Hospital beds 12.07 2023 up 10.6% 116th Treatment success rate for patients treated for MDR-TB 80.0% 2022 down 20.0% 50th New leprosy case detection rate per 1 000 000 population 0.473 2024 down 39.6% 99th Treatment success rate: HIV-positive TB cases 80 2023 up 15.9% 55th Prevalence of wasting, weight for height 2.9% 2021 up 81.2% 68th Estimated number of children (aged 0-17 years) who have lost one or 160,000 2024 down 15.8% 70th ← Previous Page 18 of 23 Next →